Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Stressgen (VSE: SSB) -- Ignore unavailable to you. Want to Upgrade?

To: William Marsh who wrote (104)	12/13/1999 5:43:00 PM
From: Heat Shock	Read Replies (1) \| Respond to of 236

To all: press release: StressGen announces results of Phase I Study. Plans to initiate PII study in cervical dysplasia newswire.ca This is excellent news. Perspective. StressGen's new web site has a file, 1999_cancer.pdf, which has a graph in it entitled "Cervical Dysplasia Market", which has a notation on it which says that they expect clinical trials for Cervical Dysplasia to end finally in the year 2004. It's a long way to Tipperary. Heat